Policy / Regulatory

NMPA Releases 109th RLD Catalog for Chemical Generics – 30 New Product Specifications Added, 24 Supplemented
GQCE testing

NMPA Releases 109th RLD Catalog for Chemical Generics – 30 New Product Specifications Added, 24 Supplemented

China's National Medical Products Administration (NMPA) released the 109th Catalog of Reference Listed Drugs for Chemical Generic Drugs, adding 30 new product specifications and supplementing information for 24 product specifications…

US Treasury Drafts China Pharma Investment Rules Likely to Preserve Licensing Deals – A Carve‑Out From Broader National‑Security Tightening

US Treasury Drafts China Pharma Investment Rules Likely to Preserve Licensing Deals – A Carve‑Out From Broader National‑Security Tightening

China's NHC Issues Landmark Rare‑Disease Notice – Mandating Province‑Wide Clinics and Quality Control Networks by End‑2026

China’s NHC Issues Landmark Rare‑Disease Notice – Mandating Province‑Wide Clinics and Quality Control Networks by End‑2026

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
NMPA Releases 93rd Batch of Reference Drugs for Generic Quality Consistency Evaluation
NMPA

NMPA Releases 93rd Batch of Reference Drugs for Generic Quality Consistency Evaluation

China's CDE Announces 95th Batch of Reference Preparations for Public Comment
CDE

China’s CDE Announces 95th Batch of Reference Preparations for Public Comment

China Ministry of Finance Restricts EU-Imported Medical Devices in Government Procurement Over RMB45 Million
State Council

China Ministry of Finance Restricts EU-Imported Medical Devices in Government Procurement Over RMB45 Million

NMPA Unveils Measures to Support High-End Medical Device Innovation with Full Lifecycle Regulation
NMPA

NMPA Unveils Measures to Support High-End Medical Device Innovation with Full Lifecycle Regulation

Show More